Healthcare, pharma and biotech stocks
Unusual options flow across 13 healthcare, pharma and biotech stocks, the drugmakers, biotechs and health insurers that move on trial data, pipelines and policy. Each name is scored on the same 0 to 100 scale, so you can watch the whole theme at once and see where the conviction is really sitting.
Smart money in healthcare, pharma and biotech stocks right now
The original RadarPulse read on this sector, live from the public feeds: the biggest scored options prints, the disclosed Congressional trades on the same names, and the confluence where the two line up, the cross-domain overlap no single-source tracker shows.
Healthcare, pharma and biotech stocks flow trackers
One page per name: the biggest scored prints, call-versus-put premium and conviction, straight from the RadarPulse flow engine. Tap any ticker for its live tape.
ETFs for the healthcare, pharma and biotech trade
Prefer to play the theme without picking one name? These funds carry the healthcare, pharma and biotech group, and their options flow reads the same way.
What healthcare, pharma and biotech stocks flow tells you
Healthcare, pharma and biotech stocks tend to move as a group. The drugmakers, biotechs and health insurers that move on trial data, pipelines and policy, so a catalyst in one name, an earnings beat, a policy headline, a guidance cut, often reprices the whole cluster. That is why watching options flow across the sector beats watching a single ticker: a burst of one-sided premium spreading from one name to its peers is the earliest sign that money is rotating into, or out of, the theme. RadarPulse scores each name the same way, so the comparison across the group is apples to apples.
How to read the sector tape
Start with the names drawing the loudest, most one-sided flow, then look at whether it is isolated or spreading. One large sweep in a single healthcare, name is a stock story; the same call premium showing up across three or four peers, and in the ETFs that hold them, is a theme story. Heavy call premium across the group means traders are paying up for upside on the whole healthcare, pharma and biotech trade; a wall of puts points to hedging or a bet it rolls over. None of it is a recommendation, flow is positioning rather than a forecast, but it tells you where conviction is building before the headlines catch up.
Why the healthcare, pharma and biotech trade is worth tracking
The strongest signals in the options market rarely sit in one name. When unusual flow, Congressional buying and 13F accumulation all point at the same corner of the market, that confluence is far more meaningful than any single print. RadarPulse was built to catch exactly that: it keeps healthcare, pharma and biotech stocks flow next to Congress disclosures and institutional filings on the same tickers, so you can see the moments when more than one kind of smart money crowds into the healthcare, pharma and biotech trade at once.
Related
Related reading
Track the smart money live
Options flow, Congress disclosures and 13F filings, scored side by side in one radar.
Join the waitlist